Thus, exploiting markers like CTLA-4, TIGIT, OX-40, 4-1BB and GITR, which we observed to be highly expressed by TIL-Tregs, can be a potential therapeutic target for the treatment of the lung cancer patients. This evidence concerns the gene TIGIT and lung carcinoma.